Nevres Koylan

Summary

Publications

  1. ncbi request reprint Effect of irbesartan monotherapy compared with ACE inhibitors and calcium-channel blockers on patient compliance in essential hypertension patients: a multicenter, open-labeled, three-armed study
    Nevres Koylan
    Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
    Blood Press Suppl 14:23-31. 2005
  2. ncbi request reprint Effect of irbesartan monotherapy compared with ACE inhibitors and calcium-channel blockers on patient compliance in essential hypertension patients: a multicenter, open-labeled, three-armed study
    Nevres Koylan
    Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
    Blood Press Suppl 1:23-31. 2005
  3. ncbi request reprint Intensive cardiovascular examination regarding blood pressure levels: evaluation of risk groups. ICEBERG study
    Kemalettin Buyukozturk
    Cardiology Department, Istanbul Medical School, Istanbul University, Istanbul, Turkey
    Blood Press 15:291-301. 2006
  4. ncbi request reprint Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension
    Huseyin Oflaz
    Department of Cardiology, Faculty of Medicine, Istanbul University, Istanbul, Turkey
    Respiration 73:751-6. 2006
  5. ncbi request reprint The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy
    Stevo Julius
    University of Michigan, Department of Internal Medicine, Division of Cardiovascular Medicine, 24 Frank Lloyd Wright Dr, PO Box 322, Lobby M, Ann Arbor, MI 48106, USA
    Hypertension 48:385-91. 2006
  6. ncbi request reprint Guideline implementation in a multicenter study with an estimated 44% relative cardiovascular event risk reduction
    Altan Onat
    Istanbul University Cerrahpasa, Turkey
    Clin Cardiol 26:243-9. 2003

Detail Information

Publications6

  1. ncbi request reprint Effect of irbesartan monotherapy compared with ACE inhibitors and calcium-channel blockers on patient compliance in essential hypertension patients: a multicenter, open-labeled, three-armed study
    Nevres Koylan
    Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
    Blood Press Suppl 14:23-31. 2005
    ..Irbesartan is therefore a suitable first-line therapy for essential hypertension in everyday clinical practice...
  2. ncbi request reprint Effect of irbesartan monotherapy compared with ACE inhibitors and calcium-channel blockers on patient compliance in essential hypertension patients: a multicenter, open-labeled, three-armed study
    Nevres Koylan
    Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
    Blood Press Suppl 1:23-31. 2005
    ..Patients were either newly diagnosed or switched from existing antihypertensive medication due to lack of efficacy or side-effects...
  3. ncbi request reprint Intensive cardiovascular examination regarding blood pressure levels: evaluation of risk groups. ICEBERG study
    Kemalettin Buyukozturk
    Cardiology Department, Istanbul Medical School, Istanbul University, Istanbul, Turkey
    Blood Press 15:291-301. 2006
    ....
  4. ncbi request reprint Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension
    Huseyin Oflaz
    Department of Cardiology, Faculty of Medicine, Istanbul University, Istanbul, Turkey
    Respiration 73:751-6. 2006
    ..Obstructive sleep apnea syndrome (OSAS) influences endothelial function and causes hypertension...
  5. ncbi request reprint The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy
    Stevo Julius
    University of Michigan, Department of Internal Medicine, Division of Cardiovascular Medicine, 24 Frank Lloyd Wright Dr, PO Box 322, Lobby M, Ann Arbor, MI 48106, USA
    Hypertension 48:385-91. 2006
    ..Moreover, these findings support the feasibility of comparative prospective trials in lower-risk hypertensive patients...
  6. ncbi request reprint Guideline implementation in a multicenter study with an estimated 44% relative cardiovascular event risk reduction
    Altan Onat
    Istanbul University Cerrahpasa, Turkey
    Clin Cardiol 26:243-9. 2003
    ..The extent of cardiovascular risk reduction by implementing coronary prevention guidelines needs to be documented in various population samples...